Update: Zhongyuan Drops Out of the Bidding
Zhongyuan Union & Cell Engineering Corp (600645: Shanghai) has dropped out of the bidding process for China Cord Blood (CO:US), citing the...
329 Views
A Buyout Offer That Needs Improvement
iKang Healthcare Group, China's largest private preventive healthcare services provider, has received a preliminary proposal from its founder,...
445 Views
Update: Mr. Kam Raises His Stake, and Nanjing Xinjiekou Ups the Pressure
The bidding war for China Cord Blood has heated up. China Cord Blood's Chairman has acquired KKR's 19% stake through a restructured purchase...
325 Views
Best of Smartkarma: The Guest Editor's Slice & Dice #23
Welcome to the 23rd Edition of the Smartkarma [Guest] Editor's Cut, a weekly summary of the key themes and ideas of the last week's research on...
414 Views
China Cord Blood: We Love a Crowd
We had previously cited the “going private” offer received by China Cord Blood as an example of the obstacles that minority investors face in...
391 Views